Latest Breaking News On - Lumiradx platform - Page 6 : comparemela.com

LumiraDx (LMDX) Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test

LumiraDx (LMDX) Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Johannes pachlerDavid waltonLeupamed medizintechnik gmbCommittee of the scientific divisionGroup for the global standardisation of hbNorwich university hospitalLumiradx limited nasdaqNorwich medical schoolLumiradx platformWorld diabetes dayLumiradx hbaChief commercial officerGarry john consultant clinical biochemistScientific divisionGlobal standardisationHonorary professor

LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test

Now Available in Europe, parts of the Middle East, Asia, Latin America, and Africa

United statesUnited kingdomCity ofJohannes pachlerDavid waltonLeupamed medizintechnik gmbCommittee of the scientific divisionGroup for the global standardisation of hbNorwich university hospitalLumiradx limited nasdaqNorwich medical schoolPrnewswire lumiradx limited nasdaqNow availableMiddle eastLatin americaWorld diabetes day

Supporting Antimicrobial Stewardship Using Point of Care CRP Testing, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) November 09, 2022 The World Antimicrobial Awareness Week, held from November 18 to 24, 2022, calls attention to the high priority

City ofUnited kingdomMatt fayVander sticheleLucy lehaneVera kovacevicDavid barberRogier hopstakenMatthew fayHoneycomb worldwide incAffairs lucy lehaneKnowsley community respiratory serviceWorld health organisationWorld antimicrobial awareness weekAdvanced practitionerCommunity respiratory service

Evaluation of a point-of-care assay for detecting SARS-CoV-2

In this application note, the performance of the LumiraDx SARS-CoV-2 & Flu A/B Test was evaluated versus RT-PCR

Application noteLumiradx platformCovid 19Point of care

Investegate |LumiraDx Inc Announcements | LumiraDx Inc: LumiraDx Partners with British In Vitro Diagnostics Association to Report on the Role of Rapid Diagnostics in Tackling Antimicrobial Resistance

Investegate announcements from LumiraDx Inc, LumiraDx Partners with British In Vitro Diagnostics Association to Report on the Role of Rapid Diagnostics in Tackling Antimicrobial Resistance

United kingdomCity ofJonathan cookeDoris ann williamsUniversity of manchesterVitro diagnostics associationDepartment of surgeryFaculty of medicine at imperial college londonDepartment of healthVitro diagnostics association toLumiradx limited nasdaqVitro diagnostic associationLumiradx partnersBritish in vitro diagnostics associationRapid diagnosticsTackling antimicrobial